Buy Biotech’s Burst Bubble… Just Not Quite Yet

Delay purchases unless several strong days of selling drive it to its 200-day moving average. More 

4 Ways to Play the Boom in Biotech Stocks

Whether you love risk or hate it, there's a way to invest in red-hot biotech stocks. Here are four options for investors of all different tolerances. More 

Is It Too Late to Buy the Rally in Small Caps?

Small cap stocks have delivered stellar returns in 2014, but the rally may be getting overextended. Is there any opportunity left for small caps? More 

5 Biotech Stocks Promising Future Rewards

Biotech is one of the dynamic sectors in our economy, and in the stock market as well. These 5 biotech stocks are solid buys in our Portfolio Grader model. More 

MYL Earnings Momentum Propels Mylan Stock to a Buy

Biogeneric drugmaker Mylan is undergoing soaring growth based on its backlog of generics waiting for U.S government approval to market. Mylan stock is a buy More 

5 Biotech Stocks That Are Buyout Candidates

These biotech stocks are this year's top M&A candidates. But even if they're not acquired, they're solid biopharma investments. More 

This Biotech Bubble Is Bound to Burst

Biotech stocks have been hot thanks to a wave of M&A speculation. That wave, however, has run its course, putting these stocks and biotech ETFs at risk. More